MGC And GlycoNex Kick Off Denosumab Trial In Japan

Partners Also Eye Global Markets For Biosimilar Rival To Prolia And Xgeva

 
• By Dave Wallace
  
Gloved hand holding injectable syringe in front of Japanese flag
MGC and GlycoNex are developing denosumab in Japan • Source: Shutterstock

More from Biosimilars

More from Products